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TDP-43 is a major component of cytoplasmic inclusions observed in neurodegenerative
diseases like frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). To
further understand the role of TDP-43 in mRNA/protein metabolism and proteostasis,
we used a combined approach with cellular and animal models overexpressing a
cytoplasmic form of human TDP-43 (TDP-43-1NLS), recapitulating ALS/FTD features.
We applied in HEK293 cells a method for labeling de novo translation, surface
sensing of translation (SUnSET), based on puromycin (PURO) incorporation. While
control cells displayed robust puromycilation, TDP-43-1NLS transfected cells exhibited
reduced ongoing protein synthesis. Next, by using a transgenic mouse overexpressing
cytoplasmic TDP-43 in the forebrain (TDP-43-1NLS mice) we assessed whether
cytoplasmic TDP-43 regulates global translation in vivo. Polysome profiling of brain
cortices from transgenic mice showed a shift toward non-polysomal fractions as
compared to wild-type littermates, indicating a decrease in global translation. Lastly,
cellular level translational assessment by SUNSET was performed in TDP-43-1NLS
mice brain slices. Control mice slices incubated with PURO exhibited robust cytoplasmic
PURO signal in layer 5 neurons from motor cortex, and normal nuclear TDP-43 staining.
Neurons in TDP-43-1NLS mice slices incubated with PURO exhibited high cytoplasmic
expression of TDP-43 and reduced puromycilation respect to control mice. These
in vitro and in vivo results indicate that cytoplasmic TDP-43 decreases global translation
and potentially cause functional/cytotoxic effects as observed in ALS/FTD. Our study
provide in vivo evidence (by two independent and complementary methods) for a role of
mislocalized TDP-43 in the regulation of global mRNA translation, with implications for
TDP-43 proteinopathies.
Keywords: TDP-43, frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), transgenic mice, protein
synthesis, animal model, proteinopathy
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INTRODUCTION
TAR DNA-binding protein 43 (TDP-43) is a ubiquitously
expressed, predominantly nuclear protein with multiple roles in
RNA processing (Buratti et al., 2001; Gao et al., 2018; Nussbacher
et al., 2019). In neurodegenerative diseases such as amyotrophic
lateral sclerosis (ALS) and frontotemporal dementia (FTD), a
key finding is that pathological TDP-43 accumulates in the
cytoplasm, forming aggregates (Arai et al., 2006; Neumann et al.,
2006; Ito et al., 2017). Nevertheless, how this mislocalization
contributes to pathogenesis is still poorly understood.
Although the most extensively described function of TDP-
43 has been its role in mRNA splicing, there has been reports
consistent with a role for this protein in translational regulation.
A proteomic study in HEK293 cells showed that TDP-43
interact extensively with proteins of the translational machinery
(Freibaum et al., 2010) and in vitro downregulation of TDP-
43 alters global translational yield through a SKAR-dependent
mechanism (Fiesel et al., 2012). Moreover, the ribosomal protein
RACK1 seems to be a key mediator of the interaction of TDP-43
with the translational machinery (Russo et al., 2017).
Using inducible transgenic mice, we demonstrated that
expression of a cytoplasmic form of TDP-43 (termed
TDP-43-1NLS) recapitulates multiple features of TDP-43
proteinopathies of the ALS/FTD spectrum, including progressive
neurodegeneration, gliosis, global gene expression changes and
behavioral abnormalities encompassing the motor, cognitive
and social domains (Igaz et al., 2011; Alfieri et al., 2014). Other
animal models with cytoplasmic TDP-43 expression, covering
from Drosophila to mammalian systems, also support the idea
that this mislocalization event might be pathogenically relevant
(Miguel et al., 2011; Walker et al., 2015; Wang et al., 2015; Yin
et al., 2019).
While most studies have focused on the regulation of global or
specific translation using cell lines or primary neurons in culture,
the consequences of in vivo TDP-43 manipulation (specifically,
of its cytoplasmic form) are virtually unknown. In this work, we
investigated both in vitro and in vivo if cytoplasmic expression
of TDP-43 modifies global protein synthesis, using two different
approaches, polysome profiling and surface sensing of translation
(SUnSET) technique.
MATERIALS AND METHODS
Surface Sensing of Translation (SUnSET) in
Cultured Cells
Cell Culture and Transfection
Myc epitope-tagged hTDP-43-1NLS construct was generated
in pcDNA 5/To plasmid (Invitrogen) using restriction sites
BamHI and XbaI, as previously described (Winton et al.,
2008). Human embryonic kidney HEK293T cells were grown
Abbreviations: ACSF, artificial cerebrospinal fluid; ALS, amyotrophic lateral
sclerosis; Ctrol, control; DOX, doxycycline; FTD, frontotemporal dementia; IF,
immunofluorescence; mRNA, messenger ribonucleic acid; NP, non-polysomal
fraction; P, polysomal fraction; PBS, phosphate buffered saline; PURO, puromycin;
RBP, RNA binding protein; RNA, ribonucleic acid; RNP, ribonucleoprotein;
SUnSET, surface sensing of translation; TDP-43, TAR DNA-binding protein 43.
in high glucose (4.5 g/L glucose) Dulbecco’s modified Eagle’s
medium (DMEM, Gibco) supplemented with 10% fetal bovine
serum, penicillin/streptomycin (100 units/ml and 100µg/ml
respectively, Thermo Fisher Scientific), and 110 mg/L of sodium
pyruvate (Thermo Fisher Scientific) in a 37◦C humidified
incubator containing 5% CO2. Cells (5 × 10
5 per well) were
plated on poly-D-lysine-coated 12mm glass coverslips in a 6-
well plate, and grown for 24 h before transfection. Lipofectamine
2000 reagent (Invitrogen) was used for transfection of constructs
(empty vector as control or hTDP-43-1NLS), according to the
manufacturer’s instructions. After 48 h, medium was replaced
with freshmediumwith or without puromycin (10µg/ml, P7255,
Sigma) for 20min and washed with PBS.
Immunocytochemistry
Cells on coverslips were fixed in 4% paraformaldehyde in
phosphate-buffered saline (PBS) for 10min, permeabilized with
0.2% Triton X-100 (Sigma) in PBS for 10min, blocked with 5%
powdered milk in PBS for 2 h, and incubated overnight with
primary antibody at 4◦C. Primary antibodies used in this study
(diluted in 5% powdered milk in PBS) were as follows: anti-
total-TDP-43 [1:5000, rabbit polyclonal anti-TDP-43 1038C (Igaz
et al., 2008)] and anti-puromycin (1:1000 dilution, MABE343,
clone 12D10, Millipore). Primary antibodies were visualized
with secondary antibodies conjugated with Alexa Fluor 488 and
Alexa Fluor 594 (1:500, donkey anti-mouse and donkey anti-
rabbit IgG, respectively, Jackson Immunoresearch), and nuclei
were detected using Hoescht 33258 (Sigma). Coverslips were
mounted in gelatin-coated slides using Fluoro-gel (Thermo
Fisher Scientific) and stored at 4◦C. Images were obtained with
a Zeiss AxioImager 2 microscope equipped with APOTOME
0.2 structured illumination, using a Hamamatsu Orca Flash
4.0 camera. Four areas per image were analyzed using ImageJ
software (version 1.52a). Mean puromycin and TDP-43 signals
were calculated and normalized to empty vector (+PURO)
group signal.
Animals
hTDP-43-1NLS line was generated as described in Igaz et al.
(2011). Monogenic tetO-TDP-1NLSmice were bred to Camk2a-
tTA mice (Jackson Laboratory) generating non-transgenic, tTA
monogenic, single tetO-TDP-43 transgenic mice, and bigenic
mice expressing hTDP-43-1NLS. Breeding mice and pups
were treated with 0.2 mg/ml doxycycline hyclate (DOX; sc-
204734A; Santa Cruz Biotechnology) in drinking water, to
avoid pre-natal and post-natal developmental effects. Transgene
expression was activated at weaning (post-natal day 28) by
removing DOX from water and mice were analyzed after
∼1 month (at post-natal day 60). Tail DNA was used for
genotyping, employing primers described in Igaz et al. (2011).
The experimental protocol for this study was approved by the
National Animal Care and Use Committee of the University
of Buenos Aires (CICUAL). All animal procedures were
performed according the NIH Guide for the Care and Use of
Experimental Animals.
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Polysome Profiling
Sucrose Gradient Preparation
Cortices of control (non-transgenic) or hTDP-43-1NLS animals
were homogenized in cold lysis buffer [15mM Tris-HCl,
pH 8.0, 300mM NaCl, 15mM MgCl2, 1% Triton X-100, 1
mg/ml heparin, protease inhibitors (Roche) and 0.1 mg/ml
cycloheximide (Sigma-Aldrich Inc.)] at a ratio of 500 µl
buffer /10mg tissue. Homogenates were then placed on ice
for 10min and centrifuged at 5,000 rpm for 10min at
4◦C. Supernatant, consisting in cytosolic extract containing
polysomes, was collected and protein concentration was
determined by bicinchoninic acid (BCA) method (Pierce).
Sucrose gradient, ranging from 15 to 50%, were prepared in
gradient buffer (15mM Tris-HCl, pH 8.0, 300mM NaCl, 5mM
MgCl2, 1 mg/ml heparin and 0.1 mg/ml cycloheximide). Briefly,
2.4ml 50% sucrose solution was added to a tube and chilled
for 30min at −80◦C. The procedure was repeated with layers
of sucrose solution at lower concentration (41.25, 32.5, 23.75,
and 15%) and stored at 4◦C if used the next day. 0.5 to
1mg of cytosolic protein extract were added to each gradient,
and centrifuged in a SW40 rotor at 35,000 rpm for 2–4 h,
at 4◦C. Five hundred microliters aliquots were separated and
absorbance at 260 nm was measured (Eppendorf Biophotometer
Plus, Germany). A peak area ratio between polysomal (P)
and non-polysomal (NP, comprising RNPs and monosomes)
fractions was determined for each group.
Western Blot
Five hundred microliters of sample from each fraction
was subjected to methanol/chloroform protein extraction
method and resuspended in sample buffer. Equal amounts
of samples were resolved on 10% sodium dodecyl Sulfate
polyacrilamyde gel electrophoresis (SDS-PAGE) and transferred
onto PVDF membranes (Immobilon-P; Millipore). After
transfer, membranes were stained with Ponceau S for total
protein load assessment, then blocked in 5% powdered milk
in 0.1% Tween-TBS, and incubated in anti-total TDP-43
primary antibody overnight (1038C, 1:20000). Detection of
primary antibody was performed with horseradish peroxidase-
conjugated secondary antibody (Jackson Immunoresearch), and
ECLwas used for blot development. Digital images were acquired
using a G-BOX Imager (Syngene). Ponceau S staining was used
as a control for equal protein loading in our immunoblot analysis
of polysomal fractions, since typical housekeeping genes are
barely detectable in polysome fractions (Reschke et al., 2013).
Surface Sensing of Translation (SUnSET) in
Brain Slices
Tissue Processing
SUnSET labeling in brain slices was adapted from Cook
et al. (2014), with some modifications. Brain coronal slices
were prepared from 8-week old (1 month off-DOX) hTDP-
43-1NLS or control mice littermates. Slices were cohort and
age matched. Mice were anesthetized with isoflurane and
decapitated; brain was removed and chilled ice-cold in 95 O2-
5% CO2-saturated, sucrose-based artificial cerebrospinal fluid
(ACSF, 220mM sucrose, 2.5mMKCl, 1mMCaCl2, 6mMMgCl2,
1.25mMNaH2PO4, 26mMNaHCO3, and 10mM dextrose). The
brain was next glued onto a vibratome stage and acute sagittal
slices (400µm) were cut. Then, the slices were recovered at
room temperature for an hour in ACSF (125mM NaCl, 2.5mM
KCl, 2mM CaCl2, 1.1mM MgCl2, 1.25mM NaH2PO4, 26mM
NaHCO3, and 10mMglucose, pH 7.4). After recovery, slices were
placed on a fine grid mesh in a petri dish and incubated in ACSF
(C- group) or ACSF supplemented with 5 µg/µl puromycin
(P7255, Sigma-Aldrich Inc.; C+ or 1NLS+ groups) at a final
volume of 30ml. Incubation time was 45min under continuous
aeration with carbogen (95% O2/ 5% CO2). Slices were then
rinsed in ACSF and fixated in 4% paraformaldehyde (Sigma-
Aldrich Inc.) in 0.1M PBS for 24 h at 4◦C. Next day, slices
were washed three times in 0.01M PBS for 10min each under
continuous agitation in an orbital shaker, incubated with 10%
sucrose in 0.01M PBS for 2 h at 4◦C and stored in 30% sucrose-
0.01M PBS at−20◦C until use.
Immunofluorescence
Brain slices containing the motor cortex [approximately bregma
1.18mm, (Paxinos and Franklin, 2008)] were selected and
washed three times in 0.01M PBS for 10min. Permeabilization
step was performed with 0.01M PBS-1% Triton X-100 for
1 h at room temperature. Next, slices were incubated with
blocking solution containing 5% normal goat serum in 0.01M
PBS-0.3% Triton X-100 for 1 h at room temperature. Sections
were immunolabeled with rabbit polyclonal anti-TDP-43
(1038C, 1:15000) and mouse monoclonal anti-puromycin
(MABE343 clone 12D10, Millipore, 1:4000) as primary
antibodies; incubation was performed first at room temperature
for 3 h followed by 48 h at 4◦C. Staining against the neuronal
marker NeuN (mouse monoclonal MAB377, Millipore, 1:1000)
or human TDP-43 protein (mouse monoclonal 60019-2,
Proteintech, 1:10000) was performed in 50µm slices as described
in Alfieri et al. (2014). Then, slices were washed three times
for 10min each with 0.01M PBS-0.04% Triton X-100 and
incubated with Alexa Fluor 594 goat anti-rabbit IgG and Alexa
Fluor 488 goat anti-mouse IgG (each at 1:500 dilution, Jackson
laboratories) for 4 h at room temperature in darkness. Slices were
washed three times for 10min with 0.01M PBS-0.04% Triton
X-100 and subjected to Hoescht staining (1:2000 dilution in
0.01M PBS) for 30min at room temperature in darkness. Finally,
sections were washed in 0.01M PBS two times (10min each)
and mounted in gelatin-coated glass slides with 30% glycerol in
0.01M PBS, covered with glass coverslips, sealed and stored in
darkness at 4◦C until use. All incubation and wash steps were
performed in a 12-well plate under continuous agitation in an
orbital shaker.
Image Detection and Analysis
Images were obtained with a Zeiss AxioImager 2 microscope
equipped with APOTOME.2 structured illumination, using a
Hamamatsu Orca Flash 4.0 camera. Two sections of layer 5
cells of motor cortex were analyzed using ImageJ software
(version 1.52a). In non-transgenic (control, C) mice incubated
with puromycin (C+), each cellular area was defined in the
green channel corresponding to puromycin signal, as well
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FIGURE 1 | Overexpression of a cytoplasmic form of TDP-43 affects global protein synthesis in HEK293 cells. (A) Workflow diagram of single cell puromycilation
measurement by SUnSET. HEK293 cells were transfected with empty vector or TDP-43-1NLS, and 72 h later, a single 20min puromycin (+ PURO) or Vehicle (VEH,
-PURO) pulse was applied to the cultures. Then, cells were subjected to total TDP-43 and puromycin IF, and Hoescht 33258 was used as a nuclear marker.
(Continued)
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FIGURE 1 | (B) Representative micrographs of total TDP-43 (red) and puromycin (green) IF staining. Control (empty vector) cells treated with vehicle (- PURO) served
to assess non-specific staining and no puromycin signal was detected, while control (+ PURO) cells exhibited robust puromycilation. In both control groups, TDP-43
labeling was nuclear (as expected for endogenous expression), while TDP-43-1NLS transfected cells showed intense, cytoplasmatic expression. A lower exposure
for the TDP-43 channel is also shown. Puromycin staining is visibly decreased in TDP-43-1NLS transfected cells (arrows). Scale bar: 10µm. (C) Quantitative analysis
of puromycilation signal revealed that cells with cytoplasmic TDP-43 (NLS+) exhibit a decreased ongoing translation. Staining intensity of TDP-43-1NLS
immunopositive cells show significant differences when compared to puromycin-labeled control cells and non-transfected (NLS-) cells. TDP-43 levels were
significantly higher in NLS+ than in the control or non-transfected groups (as expected for transgene overexpression). Data represent mean ± SEM; n = 75 cells per
condition (from three replicates). One-way ANOVA/Tukey’s multiple comparison test: ****P < 0.0001, ***P < 0.001, **P < 0.01.
as background areas between cells; the same approach was
employed in hTDP-43-1NLS animals incubated with puromycin
(1NLS+) but in the red channel (total TDP-43 signal). For
non-transgenic mice incubated in ACSF (C-), a circular area
centered in each red nucleus and background areas between cells
were quantified. Background signal was normalized to individual
cell areas, and a ratio between raw cell intensity signal and
normalized background signal was calculated. The signal from
individual cell populations and averaged signal per animal were
compared between experimental groups.
Statistical Analysis
Data are expressed as means ± SEM. Statistical analysis was
performed using a standard unpaired two-tailed student’s t-test
when comparing only two groups on one measure. A one-
way ANOVA followed by Tukey’s multiple-comparison post hoc
test was used when comparing three groups. Prism Version
8 (GraphPad Software) was used for statistical analysis and
differences were considered to be statistically significant when the
probability value was < 0.05.
RESULTS
As a first approach to study at the cellular level the effect
of cytoplasmic TDP-43 expression on protein synthesis, we
adapted the SUnSET methodology (Schmidt et al., 2009) to
measure single-cell puromycilation by immunocytochemistry
(Figure 1). Puromycin incorporation into nascent polypeptides
enables direct visualization of actively translating ribosomes.
We transfected either empty vector or TDP-43-1NLS in
HEK293 cells and, during the last 20min of the experiment,
applied puromycin (+ PURO) or vehicle (-PURO) to the
cultures (Figure 1A). Representative micrographs show
immunofluorescence staining using antibodies against total
TDP-43 or puromycin (Figure 1B). Control (empty vector) cells
treated with vehicle (-PURO) were used to assess non-specific
staining and showed virtually no puromycin signal, while
control (+PURO) cells displayed robust puromycilation. As
expected, TDP-43 staining showed nuclear, endogenous TDP-43
for both control groups, while TDP-43-1NLS transfected cells
demonstrate abundant, cytoplasmic expression in a proportion
of HEK293 cells. Remarkably, analysis of puromycilation
signal in TDP-43-1NLS transfected cells demonstrates that
cells with cytoplasmic TDP-43 (NLS+) show a decrease in
ongoing protein synthesis (arrows, Figure 1B). Quantification
of puromycin staining intensity in TDP-43-1NLS positive cells
show significant differences against both the puromycin-labeled
control cells and TDP-43-1NLS negative (non-transfected) cells
(Figure 1C). As expected, TDP-43 levels are significantly higher
in TDP-43-1NLS cells than in the control or non-transfected
groups (Figure 1C). Overall, these results demonstrate at cellular
resolution that cytoplasmic TDP-43 decreases ongoing protein
synthesis in cultured cells.
Next, we wanted to extrapolate these results in vivo, taking
advantage of our inducible human TDP-43-1NLS mouse model
with CamKIIα-driven transgene expression enriched in forebrain
neurons (Igaz et al., 2011). We first aimed to study global
protein synthesis by polysome profiling (Figure 2), a method
that allows for translational state assessment by differential
separation of mRNA-protein complexes in a sucrose gradient
(Chasse et al., 2017). TDP-43-1NLS or control mice were
generated (Figure 2A) and transgene induction was started at
P28 to avoid developmental deficits. Animals were sacrificed
at P60 (after 1 month of transgene expression), a time point
when these mice already develop ALS/FTD-like phenotypes
(Igaz et al., 2011; Alfieri et al., 2014; Walker et al., 2015)
(Figure 2B). Immunofluorescence analysis of TDP-43-1NLS
mice demonstrate robust cytoplasmic transgene expression in
cortical neurons, as revealed by an antibody that specifically
stains human TDP-43 (i.e., the transgene product) but not
endogenous mouse TDP-43 (Figure 2C). Polysome profiles
from control (non-transgenic) or TDP-43-1NLS mice cortical
homogenates show an increase in the free ribonucleoprotein
(RNP) fraction (low density) and a decrease in translationally
active fractions of high density (polysomes) in transgenic mice
(Figure 2D). Interestingly, immunoblots using total TDP-43
antibody show that overexpression of TDP-43-1NLS leads to
an increased presence of TDP-43 in most gradient fractions, but
especially in those with higher density. Quantification of the
ratio between areas under the curve for polysomal and non-
polysomal (i.e., non-translationally active) fractions demonstrate
a significant reduction in transgenic mice (Figure 2E), indicating
that cortical global protein synthesis is reduced in vivo due to
cytoplasmic TDP-43 expression.
Our polysome profiling data strongly suggest that global
translation was decreased in the brains of TDP-43 mice,
but this technique does not allow for examination of cell-
specific populations. To elucidate if TDP-43-1NLS mice display
altered ongoing protein synthesis in vivo at the neuronal level,
we applied the SUnSET method in slices from control or
transgenic mice and studied puromycilation levels in neurons
from layer 5 of the motor cortex (Figure 3). We evaluated
protein synthesis after 1 month of TDP-43-1NLS expression,
using acute thick slices (400µm) from coronal vibratome
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FIGURE 2 | Transgenic TDP-43-1NLS mice have an altered polysome profile in brain cortex. (A) Generation of hTDP-43-expressing mice. CamKIIa/tTA mice are
crossed with tetO/hTDP-43-1NLS mice. In bigenic mice, doxicycline (DOX) inhibits tTA binding to the tetracycline–responsive element (tetO), thus repressing hTDP-43
expression. Non-transgenic littermates were used as controls. (B) Timeline and experimental workflow. Mating and breeding of animals was carried in the presence of
DOX to avoid developmental effects. Transgene expression was induced at weaning (P28) by removing DOX from water (OFF DOX), and mice were analyzed at ∼1
month post-induction (P60). Then, brain cortices were subjected to polysome profiling. (C) Representative micrographs of human-specific TDP-43 antibody IF in
control (Ctrol) and TDP-43-1NLS mice at 1 month off DOX. Transgenic animals show robust cytoplasmic expression of the transgene in cortical neurons. Hoescht
33258 was used as a nuclear marker. Scale bar: 10µm. (D) Representative cortical homogenate polysome profiles in non-transgenic (Ctrol) and transgenic
(TDP-43-1NLS) mice. In TDP-43-1NLS animals, the free ribonucleoprotein (RNP) fraction is increased while the translationally active fractions (polysomes, P) are
decreased. Immunoblots against total TDP-43 using protein isolated from the individual fractions revealed that overexpression of TDP-43-1NLS increases the
presence of total TDP-43, especially in the polysomal fractions. Ponceau S was used as a loading control. (E) Quantification of the ratio between the areas under the
curve for polysomal (P) and non-polysomal (NP) fractions. Transgenic mice display a significant reduction, indicating that global translation in brain cortex is decreased
due to cytoplasmic TDP-43 expression. Data represent mean ± SEM; n = 5 for Ctrol, n = 3 for TDP-43-1NLS. *P < 0.05, significantly different from Ctrl mice
(Student’s t-test).
sections. After a short incubation with puromycin, nascent
peptides were labeled and detected at the cellular level with
anti-PURO immunofluorescence (Figure 3A). Additionally, we
used an anti-TDP-43 antibody to identify and evaluate both cells
expressing endogenous TDP-43 protein (nuclear), and neurons
expressing transgenic TDP-43-1NLS (cytoplasmic) for further
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FIGURE 3 | Cortical motor neurons from TDP-43-1NLS mice show decreased ongoing protein synthesis in vivo. (A) Diagram of the puromycilation experiment
(SUnSET technique). Coronal brain slices from non-transgenic (Ctrol) and transgenic (TDP-43-1NLS) mice were incubated in 5 µg/µl puromycin (+ PURO) or ACSF
(- PURO) for 45min. Detection of nascent puromycilated peptides and total TDP-43 was done by immunofluorescence (IF). Microscopy images of motor cortex
(Continued)
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FIGURE 3 | (layer 5) were analyzed. In Ctrol (+PURO) mice, cellular areas were defined in the green channel (puromycin signal, cell contour), as well as background
areas between cells (circle); for TDP-43-1NLS (+PURO) animals the same approach was employed but using the red channel (total TDP-43 signal). For Ctrol (-PURO)
mice, an area centered in the red nucleus (circle around the red dot) and background areas (circle) were registered. (B) Puromycin (green) and TDP-43 (red) IF in acute
cortical slices from Ctrol (-PURO and +PURO) and 1NLS (+PURO) mice. Hoescht 33258 was used as a nuclear marker. Scale bar: 50µm. (C) Higher magnification
images of representative cells as described in (B). Scale bar: 10µm. (D) Representative micrographs of double IF using the neuronal marker NeuN (red) and TDP-43
(green) in cortical sections from TDP-43-1NLS mice at 1 month off DOX. NeuN staining show that cells with cytoplasmic TDP-43 staining are neurons. Hoescht
33258 was used as a nuclear marker. Scale bar: 10µm. (E) Fold change (respect to Ctrol -PURO) analysis of TDP-43 (top) and puromycin (bottom) cellular labeling. n
= 278 for Ctrol (-PURO), n = 396 for Ctrol (+PURO), n = 203 for 1NLS (+PURO). (F) Average TDP-43 (top) and puromycin (bottom) cell signal for each experimental
mice. n = 3 for Ctrol (-PURO), n = 5 for Ctrol (+PURO), n = 3 for 1NLS (+PURO). One-way ANOVA /Tukey’s multiple comparison test; *P < 0.05, **P < 0.01, ***P <
0.001, ****P < 0.0001. Data represent mean ± SEM.
quantification. Low magnification immunofluorescence images
form Layer 5 of the motor cortex show that non-transgenic,
control mice (Ctrol) incubated with vehicle (ACSF) instead
of puromycin (-PURO) showed normal nuclear staining of
endogenous TDP-43 (Figure 3B). As expected, anti-PURO signal
was negligible, although some non-specific staining of blood
vessels can be observed (this is likely due to remaining IgG in
the slices reacting with the anti-PURO Ab raised in mice). Slices
from control mice incubated with puromycin display robust
cytoplasmic signal in most cells, indicating proper labeling of
ongoing protein synthesis. As expected, TDP-43 endogenous
levels are also nuclear and with intensity comparable to
control (-PURO) group (Figure 3B). TDP-43-1NLS mice slices
incubated with PURO show the expected pattern of increased
cytoplasmic expression of TDP-43, while these cells display a
reduction in puromycilation (Figure 3B). A high-magnification
view of cortical motor neurons from layer 5 clearly show
that cells overexpressing cytoplasmic TDP-43 display reduced
levels of anti-PURO signal (Figure 3C). Neuronal identity of
cells with cytoplasmic TDP-43 was corroborated by NeuN
and TDP-43 double immunofluorescence on thin cortical slices
from TDP-43-1NLS mice (Figure 3D). Quantification at the
cellular level demonstrates that TDP-43-1NLS mice display a
significant increase in TDP-43 signal intensity compared to both
control groups, and that PURO treatment does not affect TDP-
43 levels (Figure 3E). Cellular analysis of puromycilation in
those same neurons exhibits the expected significant increase
in control groups treated with (+ PURO) vs. without (-PURO)
puromycin. Importantly, neurons in TDP-43-1NLSmice display
a drastic reduction in protein synthesis as revealed by anti-
PURO signal (Figure 3E). These results are also evident when
we pool data from each individual animal, with a significant
reduction of puromycin signal in neurons from transgenic
mice (Figure 3F).
DISCUSSION
Protein synthesis is an essential process for all cellular types,
but neurons are particularly sensitive to proper control of
this metabolic process due to their high polarization and the
demands of plasticity mechanisms (Kapur et al., 2017). Several
studies have suggested a role for translational dysfunction in a
wide range of neurodegenerative diseases, including Alzheimer’s,
tauopathies, Huntington’s, Prion disease, and the ALS/FTD
spectrum (Ding et al., 2005; Halliday et al., 2015; Sun et al.,
2015; Meier et al., 2016; Russo et al., 2017; Kamelgarn et al.,
2018; Zhang et al., 2018; Joag et al., 2019; Koren et al., 2019).
In this report, we show both in cultured cells and, more
importantly, in cortical neurons in vivo that cytoplasmic TDP-43
leads to altered protein synthesis, expanding our understanding
of the possible role of this RNA-binding protein (RBP) in
ALS/FTD pathogenesis.
There are other examples of RBPs involved in neurological
disease (Thelen and Kye, 2019), including FMRP (related to
Fragile X syndrome) and FUS (associated with ALS/FTD)
(Donlin-Asp et al., 2017; Zhou et al., 2018). FMRP regulates
activity-dependent translation of its mRNA cargoes (Davis and
Broadie, 2017), and some of its functions are performed in
cooperation with other RBPs, including TDP-43 and Staufen
1 (Chu et al., 2019). FUS is similar in several aspects
to TDP-43, and recent reports demonstrated that disease-
related mutations in FUS can lead to suppression of global
(Kamelgarn et al., 2018) or axonal translation (Lopez-Erauskin
et al., 2018). However, most of these studies exploring the
relationship between neurodegenerative disease-related proteins
and translation were performed either in cultured cell lines
or in primary cultures derived from different transgenic
mouse models. A remarkable in vivo study recently showed
that TDP-43 and DISC1 co-aggregate in frontotemporal lobar
degeneration human samples and animal models, leading to
disruption of dendritic local translation and aberrant behavior
(Endo et al., 2018).
We show here that TDP-43-1NLS expression reduces the
amount of puromycin incorporated into translating peptides,
and found that although TDP-43-1NLS is abundantly localized
to polysome fractions, there are fewer polysome-associated
mRNAs. This raises the possibility that mislocalized TDP-43
may disrupt mRNA recruitment to polysomes. In addition,
the direction of change in translation opposes that seen
with TDP-43 knockdown (Fiesel et al., 2012), suggesting
that rather than loss of function, there is a gain of toxic
function that might be mediated by TDP-43 abnormal
expression/localization. Further studies investigating these
possibilities are warranted.
What could be the potential players involved in this
translational effect mediated by TDP-43-1NLS? A report using
SH-SY5Y cells has shown that cytoplasmic TDP-43 interacts with
both RACK1 and ribosomal protein S6 (rpS6) as demonstrated
by immunoprecipitation, and that TDP-43-1NLS co-localizes in
the cytoplasm with RACK1 and rpS6, suggesting that TDP-43
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associates to translational machinery (Russo et al., 2017). RACK1
is an associated ribosomal protein and functions as a docking site
for several proteins on the translational machinery; in addition,
it has been shown to accumulate in TDP-43 positive inclusions
in motor neurons of ALS spinal cord cases (Russo et al., 2017).
Other potential candidates are those identified in a proteomic
study using HEK293T cells in which a main cluster of TDP-43-
interacting proteins include a cytoplasmic “translational” cluster,
which contains multiple translation initiation and elongation
factors, and ribosomal subunits (Freibaum et al., 2010). Although
it is a predominantly nuclear protein, it has been previously
shown that TDP-43 shuttles between the nucleus and cytoplasm
(Winton et al., 2008), and alteration of cytoplasmic TDP-43 levels
might lead to abnormal formation of complexes involved in
translation, due to an altered stoichiometric ratio between TDP-
43 and its protein and RNA partners. Lastly, TDP-43 has been
shown to regulate the alternative splicing of SKAR (Fiesel et al.,
2012), a protein that positively affects cap-dependent protein
translation (Ma et al., 2008). TDP-43 downregulation leads in
vitro to a shift in SKAR α/β isoform ratio, which in turn increases
global translation (Fiesel et al., 2012). Interestingly, Yang et al.
(2014) used a mouse model to show that partial TDP-43 knock-
down increased SKAR isoforms with exon 3 excluded, leading to
a lower α/β isoform ratio in brain and spinal cord due to altered
alternative splicing.
Different mechanisms induced by ALS/FTD-related proteins
may lead to translational repression. Pathological forms of these
proteins can trigger stress granule formation and/or can activate
ER stress-induced pathways (i.e., PERK) leading to translational
modulation events such as eIF2α phosphorylation (Cestra et al.,
2017). High levels of misfolded proteins stimulate the Unfolded
Protein Response (UPR), which tend to stabilize proteostasis
and may lead to protein synthesis inhibition. Chronic, sustained
activation of these pathways can lead to cell death (Li et al.,
2006; Sano and Reed, 2013). ER stress markers have been
detected in samples from ALS patients and animal models
(Matus et al., 2013); remarkably, ER-stress induced HIPK2
activation and neurodegeneration has been described in TDP-
43-1NLS mice (Lee et al., 2016). Alleviation of disease-related
phenotypes can be achieved in neurodegenerative disease models
by pharmacological and genetic interventions which lead to
protein translation restoration (Moreno et al., 2013; Halliday
et al., 2017). In this line, targeting UPR signaling is an attractive
goal, given the variety of proof-of-concept drugs that act at
different steps, such as PERK activation (i.e., GSK2606414)
or eIF2α signaling (ISRIB), potentially enabling translational
recovery (Costa-Mattioli et al., 2007; Kim et al., 2014; Halliday
et al., 2015; Radford et al., 2015).
Given that our TDP-43-1NLS mouse model recapitulates
several FTD/ALS-related behavioral phenotypes (Alfieri et al.,
2014), our present results showing global translational inhibition
suggest that this alteration can be part of a pathogenicmechanism
affecting not only neuronal survival but also multiple behavioral
domains. An important step in future studies will be to apply
strategies that tend to restore protein synthesis levels and evaluate
if the neurodegenerative and behavioral phenotypes of TDP-43
animal models can be ameliorated.
In conclusion, we have shown here by two different
approaches that expression of cytoplasmic TDP-43 leads to a
decrease in global translation. Although the role of TDP-43 in
protein synthesis regulation has been discussed and explored
recently, our in vivo results underscore its importance as a
mechanistic link between the possible pathogenic molecular
changes and the clinical and pathological manifestations of TDP-
43 proteinopathies.
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